Skip to main content

Introduction to the Biophysics of the Failing Heart

  • Chapter
  • First Online:
Biophysics of the Failing Heart

Part of the book series: Biological and Medical Physics, Biomedical Engineering ((BIOMEDICAL))

Abstract

Heart failure is a primary, progressive disorder of cardiac muscle that leads to remodeling of the ventricles. While there has been much focus on the end-stage ventricular phenotype from the clinical standpoint, a better understanding of the molecular mechanisms provides significant insight regarding pathways involved in the preclinical states (the so-called Class I-II HF) where novel interventions may be targeted. Thus chapters in this book emphasize many of the biophysical components of the ventricle and working cardiac myocytes that contribute to molecular mechanisms determining its structure and function. While topics covered in each of the chapters may provide insights into the primary causes of ventricular remodeling, it is important to take into account that many of these processes (metabolic, cytoskeletal, sarcomere, and channel remodeling) are set in motion as a response to a primary stimulus and thus can be compensatory in the primary preclinical stages of disease. As illuminated in the book, it is common that the primary stimulus is biophysical in nature involving altered mechanics and stress–strain properties, for example. The transition from compensatory to pathogenic (or unregulated response) is likely to drive a significant component of the loss of function that defines the later stages of heart failure. Many of these components of cardiovascular structure and function work in concert. Yet in the early stages only subsets of the molecular framework are activated with end-stage disease representing the so-called common endpoint where all compensatory mechanisms have been exhausted. Understanding the relative role and contribution of each of these components/pathways (coupled to their specific pathogenic stimuli) in the early preclinical stages of ventricular remodeling provides both novel biomarkers and indicates new specific avenues of therapeutic intervention with a goal of altering the natural history of the disease process. As described in this book, many of the approaches and basic tools are in-hand to accomplish this understanding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. John Solaro .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Solaro, R.J., Tardiff, J.C. (2013). Introduction to the Biophysics of the Failing Heart. In: Solaro, R., Tardiff, J. (eds) Biophysics of the Failing Heart. Biological and Medical Physics, Biomedical Engineering. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7678-8_1

Download citation

Publish with us

Policies and ethics